Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.010
-0.050 (-1.63%)
At close: Feb 21, 2025, 4:00 PM
2.990
-0.020 (-0.66%)
After-hours: Feb 21, 2025, 6:41 PM EST
Sana Biotechnology Employees
Sana Biotechnology had 328 employees as of December 31, 2023. The number of employees decreased by 93 or -22.09% compared to the previous year.
Employees
328
Change (1Y)
-93
Growth (1Y)
-22.09%
Revenue / Employee
n/a
Profits / Employee
-$932,338
Market Cap
672.04M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 328 | -93 | -22.09% |
| Dec 31, 2022 | 421 | 35 | 9.07% |
| Dec 31, 2021 | 386 | 121 | 45.66% |
| Dec 31, 2020 | 265 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
SANA News
- 6 weeks ago - Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 6 weeks ago - Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Sana Biotechnology: Stock Price Rise Deserved Post Diabetes Cell Therapy Success - Seeking Alpha
- 6 weeks ago - Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why - Benzinga
- 6 weeks ago - This Biotech Stock Just Soared 240%. Why It Can Go Higher. - Barrons
- 6 weeks ago - Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression - GlobeNewsWire
- 2 months ago - Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus - Seeking Alpha
- 3 months ago - Sana Biotechnology to Present at December 2024 Investor Conferences - GlobeNewsWire